Cargando…

Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n)

The Chinese herbal formula, Shu-Yu capsule (SYC), has been successfully used to treat depression-like disorders in clinical settings. To rapidly identify the chemical constituents of SYC and its metabolites in rat serum, a simple and sensitive liquid chromatography-tandem mass spectrometry method wa...

Descripción completa

Detalles Bibliográficos
Autores principales: LI, FANG, ZHANG, YOU-BO, WEI, XIA, SONG, CHUN-HONG, QIAO, MING-QI, ZHANG, HUI-YUN
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838164/
https://www.ncbi.nlm.nih.gov/pubmed/27052341
http://dx.doi.org/10.3892/mmr.2016.5082
_version_ 1782427947041292288
author LI, FANG
ZHANG, YOU-BO
WEI, XIA
SONG, CHUN-HONG
QIAO, MING-QI
ZHANG, HUI-YUN
author_facet LI, FANG
ZHANG, YOU-BO
WEI, XIA
SONG, CHUN-HONG
QIAO, MING-QI
ZHANG, HUI-YUN
author_sort LI, FANG
collection PubMed
description The Chinese herbal formula, Shu-Yu capsule (SYC), has been successfully used to treat depression-like disorders in clinical settings. To rapidly identify the chemical constituents of SYC and its metabolites in rat serum, a simple and sensitive liquid chromatography-tandem mass spectrometry method was established in the present study. By comparing the retention times, MS and MS(n) spectra data in the literature and reference standards, a total of 73 compounds were identified from SYC. In rat serum, 62 components, including 13 prototype compounds and 49 metabolites were identified. Of these components, 14 metabolites were confirmed as novel metabolites of SYC. The results of the present study indicated that certain flavonoid glycosides and monoterpene glycosides were absorbed directly. Glucuronidation and sulfation were identified as the predominant metabolic pathways of the components in SYC. In addition, certain phase I reactions, including hydrolysis, demethylation and hydroxylation occurred in the rats. These results provide scientific evidence, which support further investigations of the pharmacology and mechanism of SYC.
format Online
Article
Text
id pubmed-4838164
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-48381642016-04-21 Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n) LI, FANG ZHANG, YOU-BO WEI, XIA SONG, CHUN-HONG QIAO, MING-QI ZHANG, HUI-YUN Mol Med Rep Articles The Chinese herbal formula, Shu-Yu capsule (SYC), has been successfully used to treat depression-like disorders in clinical settings. To rapidly identify the chemical constituents of SYC and its metabolites in rat serum, a simple and sensitive liquid chromatography-tandem mass spectrometry method was established in the present study. By comparing the retention times, MS and MS(n) spectra data in the literature and reference standards, a total of 73 compounds were identified from SYC. In rat serum, 62 components, including 13 prototype compounds and 49 metabolites were identified. Of these components, 14 metabolites were confirmed as novel metabolites of SYC. The results of the present study indicated that certain flavonoid glycosides and monoterpene glycosides were absorbed directly. Glucuronidation and sulfation were identified as the predominant metabolic pathways of the components in SYC. In addition, certain phase I reactions, including hydrolysis, demethylation and hydroxylation occurred in the rats. These results provide scientific evidence, which support further investigations of the pharmacology and mechanism of SYC. D.A. Spandidos 2016-05 2016-04-04 /pmc/articles/PMC4838164/ /pubmed/27052341 http://dx.doi.org/10.3892/mmr.2016.5082 Text en Copyright: © Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
LI, FANG
ZHANG, YOU-BO
WEI, XIA
SONG, CHUN-HONG
QIAO, MING-QI
ZHANG, HUI-YUN
Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n)
title Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n)
title_full Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n)
title_fullStr Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n)
title_full_unstemmed Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n)
title_short Metabolic profiling of Shu-Yu capsule in rat serum based on metabolic fingerprinting analysis using HPLC-ESI-MS(n)
title_sort metabolic profiling of shu-yu capsule in rat serum based on metabolic fingerprinting analysis using hplc-esi-ms(n)
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838164/
https://www.ncbi.nlm.nih.gov/pubmed/27052341
http://dx.doi.org/10.3892/mmr.2016.5082
work_keys_str_mv AT lifang metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn
AT zhangyoubo metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn
AT weixia metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn
AT songchunhong metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn
AT qiaomingqi metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn
AT zhanghuiyun metabolicprofilingofshuyucapsuleinratserumbasedonmetabolicfingerprintinganalysisusinghplcesimsn